Jetstream Capital’s Medifast MED Stock Holding History

Jetstream Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$5.66M	–	30
2021 Q2	$5.66M	Buy	+20,000	New	+$5.42M	4.36%	10

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jetstream Capital's MED Position: Q3 2021 in Review

Jetstream Capital sold out of Medifast (MED) in Q3 2021, closing a stake of 20,000 shares — an estimated $5.66M sold.

Jetstream Capital first reported a position in MED in Q2 2021 and held it in 1 quarter. The position peaked at $5.66M in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

Jetstream Capital reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
Jetstream Capital sold 20,000 Medifast shares in Q3 2021, an estimated $5.66M.
Jetstream Capital first reported a position in Medifast in Q2 2021 and held it in 1 quarter.
Jetstream Capital's Medifast position peaked at $5.66M in Q2 2021.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Jetstream Capital's 13F filing for Q3 2021, filed 15 Nov 2021.